Tag Archives: Vaccine

A study conducted by JAMA discovered that flu shots may be killing a significant number of senior citizens

Flu Shots Are Killing Senior Citizens in Record Numbers, Study Warns Scientists found vaccine-related deaths in elderly citizens are rising at an alarming rate By: Jay Greenberg |@NeonNettle on 29th July 2018 @ 8.00pm
© Neon Nettle

senior citizens are being killed by flu vaccines at an alarming rate

Researchers have found that senior citizens are being killed by flu vaccines in record numbers, and the death rate is rising at an alarming rate. A study conducted by JAMA discovered that flu shots may be killing a significant number of senior citizens. According to data collected by the study, 60 percent of people over 65-years-old are at risk. A former investigative journalist for CBS, Sharyl Attkisson, states that the study highlights the worrying rise in mortality rates among elderly citizens who are vaccinated for protection against influenza. According to Attkisson, not only do the findings prove that the flu shots do nothing to improve death rates, but they may actually be contributing to the increase in ill health and fatality. senior citizens are dying at an alarming rate due to flu shots © press Senior citizens are dying at an alarming rate due to flu shots Inquisitr reports: The study “got little attention,” she says, “because the science came down on the wrong side.” Whereas the researchers had set out to prove that the push for massive flu vaccination would save the world, the researchers were “astonished” to find that the data did not support their presupposition at all. The data actually shows that deaths increased, not decreased, among seniors following vaccination. Johns Hopkins scientist, Peter Doshi, Ph.D., issued a report in the prestigious British Medical Journal, according to NewsLI, asserting that the CDC policy of routinely recommending the flu vaccine is being based on “low-quality studies that do not substantiate claims.” He says there is no evidence that the vaccine reduces deaths among senior citizens. Interestingly, Doshi cites an Australian study which found significant risks for children as well, stating that “one in every 110 children under the age of five had convulsions following vaccinations in 2009 for H1N1 influenza.” During the drug trials for the Fluzone flu vaccine, 23 seniors out of 3,833 died after receiving the shot, according to the drug’s package insert, reported by Health Impact News. Another 226 experienced “serious adverse effects.” The manufacturer denies any connection between the deaths and the flu vaccine. Seniors Told Get Flu Vaccine There appears to be growing public skepticism that the flu vaccine is as beneficial as the experts say, according to an earlier Inquisitr report. The level of doubt is strongly correlated to the incidence of accounts of research fraud in the vaccine industry, an industry which makes billions of dollars of profit every year. deaths among the elderly are rising due to a recent study © Press Deaths among the elderly are rising due to a recent study Often when an article about the dangers of a vaccine comes out, there are people who write in to tell about a family member who was harmed by the vaccine and the flu vaccine for senior citizens in no exception. A number of people have written to report that their grandmother, or uncle, or brother died shortly after getting a flu shot, sometimes after receiving their first ever such shot. Their stories are frequently minimized, yet the government pays out more compensation from the flu vaccine than any other vaccine. Despite this, it is increasingly expected that every senior citizen line up for their annual flu shot. A nursing home near Atlanta, Georgia, now reports a devastating outcome to such a policy, according to Health Impact News. All of the residents of the Hope Assisted Living & Memory Care were given a flu vaccine on Friday, November 7. Every one of the senior citizens developed an immediate fever. Within the week following, five of them died. The source reports that the facility’s typical pattern is one or two losses every six months, frequently due to Alzheimer’s. “The facility is not saying they are related to the flu shot but we all know they are, and they know they are.” Questions must be asked, then, such as: do the benefits of getting a flu vaccine outweigh the risks, especially among vulnerable senior citizens? Or would they be better off choosing to reject the shot? Who benefits if evidence showing the harm of the vaccine is buried? And what would be the motive for fabricating evidence of harm if none exists? If the facts are as solid as some insist, then why do they seem to be threatened by the data being challenged? Shouldn’t truth be able to stand up under scrutiny?

Read more at: http://www.neonnettle.com/news/4644-flu-shots-are-killing-senior-citizens-in-record-numbers-study-warns
© Neon Nettle

READ MORE: Doctor Blows Whistle on Flu Shot – ‘It’s Designed to Spread Cancer’

Scientists grapple with ethics in rush to release Ebola vaccines

By Kate Kelland

LONDON Sun Sep 28, 2014 9:28am EDT

(Reuters) – Normally it takes years to prove a new vaccine is both safe and effective before it can be used in the field. But with hundreds of people dying a day in the worst ever outbreak of Ebola, there is no time to wait.

In an effort to save lives, health authorities are determined to roll out potential vaccines within months, dispensing with some of the usual testing, and raising unprecedented ethical and practical questions.

“Nobody knows yet how we will do it. There are lots of tough real-world deployment issues and nobody has the full answers yet,” said Adrian Hill, who is conducting safety trials on healthy volunteers of an experimental Ebola shot developed by GlaxoSmithKline.

Hill, a professor and director at the Jenner Institute at Britain’s University of Oxford, says that if his results show no adverse side-effects, GSK’s new shot could used in people in West Africa by the end of this year.

Even if a drug is shown to be safe, it takes longer to prove it is effective – time that is simply not available when cases of Ebola infection are doubling every few weeks and projected by the World Health Organization to reach 20,000 by November.

Among questions that scientists are grappling with: should an unproven vaccine be given to everybody, or just a few? Should it be offered to healthcare workers first? The young before the old? Should it be used first in Liberia where Ebola is spreading fastest, or Guinea where it is closer to being under control?

Should people be told to assume it will protect them from Ebola? Or should they take all the protective measures they would if they hadn’t been vaccinated? And if so, how will anyone know whether the vaccine works?

GSK is one of several drug firms that have either started or announced plans for human trials of candidate Ebola vaccines. Others include Johnson & Johnson, NewLink, Inovio Pharmaceuticals and Profectus Biosciences.

The WHO says it hopes to see small-scale use of the first experimental Ebola vaccines in the West Africa outbreak by January next year.

It has convened vaccine specialists, epidemiologists, pharmaceutical companies and ethicists, for a meeting on Monday and Tuesday to discuss the moral and practical issues.

“Normally safety is the absolutely paramount thing when you’re developing a new vaccine, but this time we’re going to have to take more risks,” said Brian Greenwood, a professor at the London School of Hygiene and Tropical Medicine who will take part in the WHO-led meeting.

“Quite how we do that, and what risks we take, hasn’t really been thought through yet. That’s what people are trying to figure out.”

TWO THINGS AT THE SAME TIME

The chaos caused by the epidemic itself makes it even more difficult to deploy and track use of a new vaccine, said Hill.

“You’re trying to do two things at the same time: you’re trying to evaluate a vaccine and deploy it – when normally you would evaluate the vaccine first, by doing a randomized double blind controlled trial, and then you’d deploy it if it was shown to be safe and effective.”

Because Ebola virus is so deadly, those who receive a trial vaccine must be told to take all other precautions and protect themselves fully. This could make it harder for researchers to decipher whether the protective clothing and safety protocols, or the new vaccine, is what kept them safe.

Normally researchers testing a vaccine would give some volunteers a placebo, or dummy, to create a “control” group to compare against those who get the real drug. That seems unthinkable in a situation where disease with a death rate of up to 90 percent is raging through villages.

“Would it be ethical to do a trial where some people don’t get the vaccine because they are in the control group? Most people think it wouldn’t be – especially if you have reasonable evidence that the vaccine might work,” said Hill.

Jeremy Farrar, an infectious diseases expert and director of the Wellcome Trust medical charity, said limited supplies of any candidate vaccine could result in a form of natural control group being formed anyway. Researchers can compare populations where the vaccine is available with those where it isn’t.

GSK has said it is aiming to have 10,000 doses of its experimental shot by the end of the year, while Canada has given 800 vials of the NewLink candidate vaccine to the WHO, expected to yield at least 1,500 doses.

Most experts interviewed by Reuters favor the idea of the first doses going to frontline healthcare workers, since their exposure to risk is so high. Researchers could then compare infection rates among health workers who receive the vaccine to those working in regions still waiting for it.

Peter Piot, a co-discoverer of the Ebola virus in 1976 and now director of the London School of Hygiene and Tropical Medicine said that however complicated the ethics, reverting to the traditional years-long process of testing vaccines, and withholding them from West Africa until then, is not an option.

“It may be that without a vaccine, we can’t really stop this epidemic,” he said.

(Reporting by Kate Kelland; Editing by Peter Graff)

CONTINUE READING…

Health workers in other areas have been attacked by villagers who mistakenly believed the visitors were actually spreading the fatal virus.

Team of health workers and journalists helping fight Ebola found dead in Guinea
Nine Guineans, including three reporters, went missing after being attacked in village.
Their bodies were found Thursday, government spokesperson says.

BY Deborah Hastings
NEW YORK DAILY NEWS
Thursday, September 18, 2014, 5:26 PM

A team of medical workers and journalists trying to raise awareness about the deadly Ebola outbreak in West Africa have been found dead in Guinea, authorities said Thursday.

The group had disappeared after being attacked in a remote village near the city of Nzerekore.

Villagers had pelted the nine Guineans with stones as they visited. The government said eight bodies were recovered. Among the dead were three radio journalists. Their identities have not been revealed.

The team was believed to have been held captive before the death of its members. Health workers in other areas have been attacked by villagers who mistakenly believed the visitors were actually spreading the fatal virus.

The current Ebola outbreak was first identified in the country in March. More than 2,600 people have died in surrounding countries, including Sierra Leone and Liberia.

CONTINUE READING…

US to test Ebola vaccine on humans, may bring some hope

US to test Ebola vaccine on humans, may bring some hope. This is good news that development of Ebola vaccine has been placed on fast track.

A few months ago when reports had surfaced about people dying of Ebola virus in West African countries of Liberia, Guinea and Sierra Leone, many had thought the virus would be contained. But the increase in number of deaths from the disease has alarmed the world.

Now the World Health Organisations and even agencies in the US are showing urgency to stamp out the disease. There are fears that if left like this the situation might get out of control with the disease spilling over to other countries and even reaching America through travellers. Besides despatching experts to the Ebola-hit region, Federal officials are working overtime to develop an Ebola vaccine.
Measles outbreak triggers fresh emphasis on MMR vaccinations
It is understood that once it is developed the drugs human trials would begin in September. This has been confirmed by a top National Institutes of Health official. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said: “We’re trying to go as quickly as we can give the emerging nature of the situation.”

The good thing is that the efforts have started yielding positive results with reports surfacing that the vaccine on which researchers are working have given “pretty encouraging” results on tests in primates.

CONTINUE READING…